S9 Ep9: FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis
Jul 10, 2023
13:53
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Gotlib discusses the significance of the FDA approval of avapritinib in indolent systemic mastocytosis, key findings from the PIONEER trial, and the quality of life benefits that avapritinib provides for patients in this population.
OncLive® On Air